Otsuka Pharmaceutical Development & Commercialization, Inc., and Spencer Health Solutions, Inc., Enter Agreement for Use of spencer® Smart Hub in Clinical Trials and Commercial Applications
Excerpt from the Press Release:
PRINCETON, N.J. & MORRISVILLE, N.C.–(BUSINESS WIRE)–Otsuka Pharmaceutical Development & Commercialization, Inc., and Spencer Health Solutions, Inc., today announced an agreement to jointly create a transformational patient experience using the spencer® smart hub, the world’s first at-home medication device that connects patients and their care teams through an easy-to-use, fully integrated platform.
As part of the agreement, Otsuka will evaluate the spencer device to improve medication adherence and patient engagement in clinical trials and commercial applications.
“Our commitment to the democratization of clinical trials, patient engagement and leveraging technology to improve diversity and inclusion in clinical research helps drive our success at Otsuka,” said Christoph Koenen, MD, executive vice president & chief medical officer, Otsuka Pharmaceutical Development & Commercialization, Inc. “The spencersmart hub will be an asset in our efforts to improve treatment plans for people living with challenging health conditions.”
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?